scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2024 Earnings Call Transcript March 19, 2025
scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.4.
Operator: Good afternoon, and welcome to scPharmaceuticals Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a question-and-answer session. [Operator Instructions] As a reminder, today’s...
